Skip to search formSkip to main contentSkip to account menu

imiglucerase

Known as: imiglucerase [Chemical/Ingredient] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
ObjectiveWe studied the effect of long-term alglucerase/imiglucerase (Ceredase®/Cerezyme®, Genzyme, a Sanofi company, Cambridge… 
2013
2013
Background. Enzyme Replacement Therapy (ERT) is the standard of care in Gaucher disease. The effects of withdrawal or reduced… 
2010
2010
Gaucher disease (GD), the inherited deficiency of the lysosomal enzyme glucocerebrosidase, presents with a wide range of symptoms… 
Review
2009
Review
2009
BACKGROUND Gaucher disease (GD) is a highly heterogeneous disorder with multisystem involvement. Specific therapeutic goals for… 
2004
2004
BACKGROUND Gaucher disease is the most common lysosomal storage disorder caused by the insufficiency of the lysosomal enzyme… 
2002
2002
BACKGROUND AND PURPOSE The management of Gaucher disease has been dramatically improved by the development of enzyme replacement… 
2001
2001
We report resolution of ground-glass appearance in high-resolution computed tomography of chest in a 6-year-old girl who had… 
1998
1998
BACKGROUND/AIMS In the early 1990s, enzyme replacement therapy with modified placental glucocerebrosidase (alglucerase, Genzyme…